Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma
Completed
Sunovion
Phase 3
2003-01-01
The purpose of this study is to evaluate the safety of levalbuterol as compared to racemic
albuterol based on the frequencies of adverse events reporting during a 12-month period of
chronic dosing of adolescent and adult subjects with asthma.
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
Completed
Sunovion
Phase 3
2002-05-01
The primary purpose of this study was to investigate the efficacy of levalbuterol compared to
a placebo and compared to albuterol in the treatment and prevention of bronchoconstriction in
adolescent and adult subjects with asthma, with all treatments administered 4 times a day
(QID).
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
Completed
Sunovion
Phase 3
2002-12-01
The primary objective of this study is to investigate the efficacy of levalbuterol 90 ug (2
actuations, 45 ug each) versus placebo (2 actuations) in the treatment and prevention of
bronchoconstriction in adolescent and adult subjects with asthma, with all treatments
administered 4 times a day (QID).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.